-
公开(公告)号:EP3027248A2
公开(公告)日:2016-06-08
申请号:EP14749996.6
申请日:2014-08-04
CPC分类号: A61M5/3134 , A61M5/20 , A61M5/2033 , A61M5/24 , A61M2005/3142 , A61M2205/19
摘要: An assembly for an auto injector device, the assembly including a syringe support for supporting a syringe by limiting forward axial movement of the syringe relative to the syringe support, and a guard element attachable to the syringe support by an attachment so that the guard element is axially restrained both axially forwardly and axially rearwardly relative to the syringe support by the attachment. Forwardly directed axial loads received by the guard element are transmitted to the syringe support via the attachment.
-
公开(公告)号:EP3011027A1
公开(公告)日:2016-04-27
申请号:EP14731259.9
申请日:2014-06-17
申请人: UCB Biopharma SPRL
IPC分类号: C12N15/113
CPC分类号: C12N15/113 , C12N2310/13 , C12N2310/51 , C12N2310/532 , C12N2320/51 , C12P21/00
摘要: The present disclosure relates to a method of preparing exonuclease resistant molecules of block- decoys, use of the molecules in methods of modulating expression of recombinant proteins, particularly in vitro, for example by down regulation or inhibition of one or more transcription factors, and novel molecules of block-decoys, especially those obtained or obtainable from the methods herein. The disclosure also relates to use of said block decoys in vitro and in therapy. In one aspect there is provided a method for regulating recombinant gene expression in vitro comprising the steps of: a) providing a host cell encoding one or more recombinant genes for expression, b) contacting the cell with a exonuclease resistant block-decoy under condition suitable for the block-decoy to gain entry into the cell, and c) expressing the recombinant protein or protein.
摘要翻译: 本公开内容涉及制备嵌段诱饵的外切核酸酶抗性分子的方法,所述分子在调节重组蛋白表达的方法中的用途,特别是在体外,例如通过下调或抑制一种或多种转录因子,以及新颖的 特别是从本文的方法获得或可获得的那些块诱饵的分子。 本公开还涉及在体外和治疗中使用所述块诱饵。 在一个方面,提供了一种用于在体外调节重组基因表达的方法,其包括以下步骤:a)提供编码一种或多种用于表达的重组基因的宿主细胞,b)在合适的条件下使细胞与外切核酸酶抗性阻滞诱饵接触 用于阻止诱饵进入细胞,和c)表达重组蛋白或蛋白质。
-
公开(公告)号:EP2523972B1
公开(公告)日:2016-03-30
申请号:EP11700101.6
申请日:2011-01-12
申请人: UCB Biopharma SPRL
发明人: ADAMS, Ralph , DAVE, Emma
CPC分类号: C07K16/468 , C07K16/00 , C07K16/18 , C07K16/241 , C07K16/244 , C07K16/248 , C07K16/2878 , C07K2317/31 , C07K2317/55 , C07K2317/56 , C07K2317/62 , C07K2317/626 , C07K2317/64 , C07K2317/92
-
公开(公告)号:EP2240494B1
公开(公告)日:2016-03-30
申请号:EP09703360.9
申请日:2009-01-20
申请人: UCB Biopharma SPRL
IPC分类号: C07D495/04 , C07D519/00
CPC分类号: C07D495/04 , C07D519/00
-
公开(公告)号:EP2046832B1
公开(公告)日:2015-12-02
申请号:EP07789062.2
申请日:2007-07-24
申请人: UCB Biopharma SPRL
IPC分类号: C07K16/00
CPC分类号: C07K16/00 , C07K2317/52 , C07K2317/734
-
公开(公告)号:EP2879737A1
公开(公告)日:2015-06-10
申请号:EP13741801.8
申请日:2013-07-29
申请人: UCB Biopharma SPRL
发明人: McLOUGHLIN, Martin John , HEALD, Michael James David , MELZI, Ilario , VERLAAK, Stefan , PALOMBI, Tatiana
CPC分类号: A61M5/1456 , A61M5/002 , A61M5/158 , A61M5/20 , A61M5/3134 , A61M5/31505 , A61M5/31515 , A61M5/3202 , A61M5/3204 , A61M5/326 , A61M2005/2013 , A61M2005/206 , A61M2005/2477 , A61M2205/50 , A61M2205/502 , A61M2205/505 , A61M2205/583 , A61M2205/586 , A61M2205/8206
摘要: Provided is a cassette unit suitable for use with an auto-injector having an electrically powered drive unit. The cassette unit comprises a cassette unit housing defining a cassette unit housing cavity and a needle projection aperture. The housing cavity may receive a syringe. Axially movable within the barrel of the syringe for forward movement into contact with the syringe plunger, there is a plunger slaving part defining a circumferential wall arranged for frictional sliding relationship with the inner wall of the barrel, a rear drive-receiving face and a front plunger-contacting face. The plunger slaving part is arranged such that when a drive load is applied to its rear drive-receiving face to bring the front plunger-contacting face into contact with the plunger the drive load is evenly transmitted. The circumferential wall is provided with slide restrictors that restrict frictional sliding movement thereof in relation to the inner wall of the barrel.
摘要翻译: 提供了一种适用于具有电驱动单元的自动注射器的盒式单元。 盒单元包括限定盒单元容纳腔和盒突出孔的盒单元壳体。 壳体腔可以容纳注射器。 在注射器筒体内轴向移动以向前移动而与注射器柱塞接触,存在柱塞从动部件,其限定了与筒体的内壁摩擦滑动关系设置的周向壁,后部驱动器接收面和前部 柱塞接触面。 柱塞从动部件设置成当驱动负载施加到其后驱动接收面上以使前柱塞接触面与柱塞接触时,驱动负载均匀地传递。 周壁设有滑动限制器,该滑动限制器限制其相对于筒的内壁的摩擦滑动。
-
97.
公开(公告)号:EP2872511A1
公开(公告)日:2015-05-20
申请号:EP13734128.5
申请日:2013-07-05
申请人: UCB Biopharma SPRL
发明人: BENTLEY, Jonathan Mark , BROOKINGS, Daniel Christopher , BROWN, Julien Alistair , CAIN, Thomas Paul , GLEAVE, Laura Jane , HEIFETZ, Alexander , JACKSON, Victoria Elizabeth , JOHNSTONE, Craig , LEIGH, Deborah , MADDEN, James , PORTER, John Robert , SELBY, Matthew Duncan , ZHU, Zhaoning
IPC分类号: C07D487/04 , A61K31/425 , A61P29/00
CPC分类号: C07D491/107 , A61K31/4985 , A61K31/506 , A61K31/5377 , A61K31/5513 , C07D451/02 , C07D471/08 , C07D487/04
摘要: A series of imidazo[1,2-α]pyrazine derivatives, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorder; and oncological disorders.
摘要翻译: 因此,作为人TNFα活性的有效调节剂的一系列咪唑并[1,2-α]吡嗪衍生物在治疗和/或预防各种人类疾病中是有益的,包括自身免疫性和炎症性疾病; 神经和神经退行性疾病; 疼痛和伤害性疾病; 心血管疾病; 代谢紊乱; 眼部疾病 和肿瘤疾病。
-
98.
公开(公告)号:EP2872508A1
公开(公告)日:2015-05-20
申请号:EP13739376.5
申请日:2013-07-05
申请人: UCB Biopharma SPRL
发明人: BENTLEY, Jonathan Mark , BROOKINGS, Daniel Christopher , BROWN, Julien Alistair , CAIN, Thomas Paul , CHOVATIA, Praful Tulshi , FOLEY, Anne Marie , GALLIMORE, Ellen Olivia , GLEAVE, Laura Jane , HEIFETZ, Alexander , HORSLEY, Helen Tracey , HUTCHINGS, Martin Clive , JACKSON, Victoria Elizabeth , JOHNSON, James Andrew , JOHNSTONE, Craig , KROEPLIEN, Boris , LECOMTE, Fabien Claude , LEIGH, Deborah , LOWE, Martin Alexander , MADDEN, James , PORTER, John Robert , QUINCEY, Joanna Rachel , REED, Laura Claire , REUBERSON, James Thomas , RICHARDSON, Anthony John , RICHARDSON, Sarah Emily , SELBY, Matthew Duncan , SHAW, Michael Alan , ZHU, Zhaoning
IPC分类号: C07D471/04 , C07D519/00 , A61K31/437 , A61P29/00
CPC分类号: C07D471/04 , A61K31/437 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K31/541 , A61K31/5513 , A61K31/554 , C07D491/107 , C07D519/00
摘要: A series of imidazo[1,2-a]pyridine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
摘要翻译: 因此,作为人类TNFα活性的有效调节剂的一系列式(I)的咪唑并[1,2-a]吡啶衍生物在治疗和/或预防各种人类疾病中是有益的,包括自身免疫性和炎症性疾病; 神经和神经退行性疾病; 疼痛和伤害性疾病; 心血管疾病; 代谢紊乱; 眼部疾病; 和肿瘤疾病。
-
公开(公告)号:EP2858983A1
公开(公告)日:2015-04-15
申请号:EP13727932.9
申请日:2013-06-11
申请人: UCB Biopharma SPRL
发明人: BROOKINGS, Daniel, Christopher , CALMIANO, Mark, Daniel , GALLIMORE, Ellen, Olivia , HORSLEY, Helen, Tracey , HUTCHINGS, Martin, Clive , JOHNSON, James, Andrew , KROEPLIEN, Boris , LECOMTE, Fabien, Claude , LOWE, Martin, Alexander , NORMAN, Timothy, John , PORTER, John, Robert , QUINCEY, Joanna, Rachel , REUBERSON, James, Thomas , SELBY, Matthew, Duncan , SHAW, Michael, Alan , ZHU, Zhaoning , FOLEY, Anne Marie
IPC分类号: C07D401/04 , C07D235/12 , A61K31/4427 , A61P29/00
CPC分类号: C07D235/12 , A61K31/4184 , A61K31/4192 , A61K31/4439 , A61K31/444 , A61K31/454 , A61K31/4709 , A61K31/4725 , A61K31/506 , A61K31/5377 , A61K31/541 , A61K31/551 , C07D401/04 , C07D401/14 , C07D403/04 , C07D405/06 , C07D491/107
摘要: A series of benzimidazole derivatives, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
-
-
-
-
-
-
-
-
-